Rituximab for troublesome cases of childhood nephrotic syndrome

doi:10.5409/wjcp.v3.i4.69

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8855)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

473

WORD

332

HTML

2779

Figures (1-1)

259

Tables (1-1)

238

Sum=4081

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

562

Download

1342

Sum=1904

Publishing Process of This Article

Item

Count

Browse

1110

Download

1760

Sum=2870

Nov 8, 2014 (publication date) through Jan 1, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Pediatr. Nov 8, 2014; 3(4): 69-75
Published online Nov 8, 2014. doi: 10.5409/wjcp.v3.i4.69

Open in New Tab Full Size Figure Download Figure

Figure 1 Rituximab vs conventional treatment in steroid resistant nephritic syndrome. SRNS: Steroid resistant nephritic syndrome; Pred: Prednisone; CSA: Cyclosporine A; RTX: Rituximab. From ref.[20].

Citation: Safdar OY, Aboualhameael A, Kari JA. Rituximab for troublesome cases of childhood nephrotic syndrome. World J Clin Pediatr 2014; 3(4): 69-75
URL: https://www.wjgnet.com/2219-2808/full/v3/i4/69.htm
DOI: https://dx.doi.org/10.5409/wjcp.v3.i4.69